SCHEMBL23708489

SCHEMBL23708489

NC(=O)c1cc(-c2ncc[nH]2)ccc1N1CCCC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.53
MEN1 O00255 1/20 0.53
MAPT P10636 1/20 0.53
THRB P10828 1/20 0.53
ALOX15 P16050 1/20 0.53
GFER P55789 1/20 0.53
YWHAG P61981 1/20 0.53
KMT2A Q03164 1/20 0.53
HSD17B10 Q99714 1/20 0.53
HTT P42858 1/20 0.52
CDC7 O00311 2/20 0.50
CDK9 P50750 1/20 0.50
ROCK2 O75116 1/20 0.49
MAP4K4 O95819 1/20 0.49
CDK2 P24941 1/20 0.49
GSK3B P49841 1/20 0.49
CLK4 Q9HAZ1 1/20 0.49
IRAK4 Q9NWZ3 1/20 0.49
CSNK1A1 P48729 1/20 0.49
TYRO3 Q06418 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5223329 0.89 CDC7 (0.63) KDM4EMEN1MAPTTHRBALOX15
SCHEMBL23707892 0.79 KDM4E (0.55) KDM4EMEN1MAPTTHRBALOX15
SCHEMBL23708152 0.78 CDC7 (0.80) KDM4EMEN1MAPTTHRBALOX15
SCHEMBL8782056 0.77 CSNK1A1 (0.54) KDM4EGFERKMT2ACSNK1A1TYRO3
SCHEMBL23707895 0.74 KDM4E (0.63) KDM4EMEN1MAPTTHRBALOX15
SCHEMBL23707919 0.73 MKNK1 (0.58) KDM4EMEN1MAPTTHRBALOX15
SCHEMBL7427024 0.72 CSNK1A1 (0.48) KDM4EMAPTCDC7CSNK1A1TYRO3
SCHEMBL5224122 0.72 ALDH1A1 (0.53) KDM4EMEN1MAPTKMT2AHTT
SCHEMBL2351161 0.70 NISCH (0.53) KDM4EMEN1MAPTTHRBALOX15
SCHEMBL17774819 0.70 KDM4E (1.00) KDM4EMEN1MAPTTHRBALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021154966-A1 COMPOUNDS AND COMPOSITIONS FOR USE IN TREATING SKIN DISORDERS KAMARI PHARMA LTD. (IL) 2021-08-05 WO disclosed